South Korea · Research startup
South Korea · iN Therapeutics
iN Therapeutics is a spin-off biotech, from local leading pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery platform for ion channel, Nav1.7 non-opioid an
Funding reportedLast round: Series B
About iN Therapeutics
iN Therapeutics is a spin-off biotech, from local leading pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery platform for ion channel, Nav1.7 non-opioid an
algesic, and the treatments for hearing loss and neurological diseases. iN Therapeutics has the world's best ion channel evaluation platform and development know-how through developing a new drug targeting ion channel which is a promising target of various CNS (Central Nervous System) diseases for about 10 years.
What company datasets say iN Therapeutics raised
Funding, as reported
On a portfolio page
Investors who name them
Each firm lists iN Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health carefirst-in-class drugspain managementdwp17061 ic50neurodegenerative diseaseskcc2medical researchdrug candidatesselectivity profileperipheral nervous systemneurodegenerationbiotech researchdwp17061hospital & health carenav1.7mechanism of action
Built with from their website
Google MapsGoogle Tag ManagerNAVERViewport MetaGoogle Maps PlatformGoogle Font APIMobile FriendlyOpen GraphjQueryGoogle Analytics
+7 more
Google Maps (Non Paid Users)Naver AnalyticsGoogle Analytics 4KakaoNginxjsDelivrSlick
- Sector
- Research
- Industry code
- NAICS 541714, 325412, SIC 2834
- Region
- Gyeonggi-do
- Full record
- Every detail in the company directory
Research in South Korea
Startups like it
Is this your company?
Add your raise, your deck and your story, and put iN Therapeutics in front of investors. Or tell us what we have wrong.